Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.
Authors: Nguyen D; The University of Texas MD Anderson Cancer Center Houston United States., Kantarjian HM; The University of Texas MD Anderson Cancer Center Houston, Tx United States., Bidikian A; The University of Texas MD Anderson Cancer Center Houston, Tx United States., Manuel CM; The University of Texas MD Anderson Cancer Center United States., Qiao W; The University of Texas MD Anderson Cancer Center Houston, Texas United States., Ning J; The University of Texas MD Anderson Cancer Center Houston, TX United States., DiNardo CD; The University of Texas MD Anderson Cancer Center Houston, TX United States., Kadia TM; The University of Texas MD Anderson Cancer Center Houston, TX United States., Daver N; The University of Texas MD Anderson Cancer Center Houston, TX United States., Borthakur G; The University of Texas MD Anderson Cancer Center Houston, TX United States., Jabbour E; The University of Texas MD Anderson Cancer Center Houston, TX United States., Yilmaz M; The University of Texas MD Anderson Cancer Center Houston, Texas United States., Maiti A; The University of Texas MD Anderson Cancer Center Houston, TX United States., Sasaki K; Institute of Science Tokyo Houston, TX United States., Montalban-Bravo G; The University of Texas MD Anderson Cancer Center Houston, TX United States., Chien K; The University of Texas MD Anderson Cancer Center Houston, TX United States., Hammond D; The University of Texas MD Anderson Cancer Center Houston, TX United States., Pierce S; The University of Texas MD Anderson Cancer Center Houston, TX United States., Andreeff M; The University of Texas MD Anderson Cancer Center Houston, Tx United States., Ravandi F; The University of Texas MD Anderson Cancer Center Houston, Texas United States., Short NJ; The University of Texas MD Anderson Cancer Center Houston, TX United States., Garcia-Manero G; The University of Texas MD Anderson Cancer Center Houston, TX United States., Issa GC; The University of Texas MD Anderson Cancer Center Houston, Texas United States.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-26-0951